JPM26: Immunocore Signals Entry into Type 1 Diabetes [Yahoo! Finance]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Yahoo! Finance
its ImmTAX TCR-bispecific platform beyond oncology and infectious disease into autoimmune conditions, including type 1 diabetes (T1D). The company plans to dose the first patient in a Phase I trial of IMC S118AI, an ImmTAAI (Immune mobilising monoclonal TCRs Against AutoImmune disease) candidate targeting T1D, in the first half of 2026, with a second autoimmune asset, IMC U120AI for inflammatory dermatology, expected to enter the clinic in the second half of the year. This announcement marks Immunocore's formal move into disease-modifying T1D immunotherapy and positions its TCR-based approach as a potential future competitor to existing and emerging immune intervention strategies. T1D is a chronic, immune-mediated disease characterised by T cell–driven destruction of insulin-producing pancreatic beta cells, leading to absolute insulin deficiency and lifelong dependence on exogenous insulin. The disease typically presents in childhood or adolescence but can occur at any age, and is a
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]Yahoo! Finance
- Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Immunocore (NASDAQ:IMCR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Immunocore (NASDAQ:IMCR) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "strong-buy" rating.MarketBeat
IMCR
Earnings
- 11/6/25 - Beat
IMCR
Sec Filings
- 1/9/26 - Form 8-K
- 12/8/25 - Form 4
- 12/1/25 - Form 4
- IMCR's page on the SEC website